Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 15 | 8 | 41 | 51 | 25 | 138 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 7 | 6 | 16 | 47 | 18 | 93 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 6 | 1 | 21 | 10 | 7 | 45 |
Hyperglycemia | D006943 | HP_0003074 | R73.9 | 1 | 1 | 2 | 10 | 1 | 15 |
Gestational diabetes | D016640 | HP_0009800 | O24.4 | — | 3 | 2 | 3 | 3 | 11 |
Overweight | D050177 | — | E66.3 | — | — | 1 | 1 | 1 | 3 |
Hypoglycemia | D007003 | HP_0001943 | E16.2 | — | — | — | 2 | 1 | 3 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | 1 | 1 | — | 2 |
Body weight | D001835 | EFO_0004338 | — | — | — | — | 1 | — | 1 |
Weight gain | D015430 | HP_0004324 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pregnancy in diabetics | D011254 | — | O24.91 | — | 1 | 1 | — | 1 | 3 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 3 | 1 | — | — | 3 |
Hypertension | D006973 | EFO_0000537 | I10 | — | — | 1 | — | 1 | 2 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | 1 | — | — | 1 |
Hypercholesterolemia | D006937 | HP_0003124 | — | — | — | 1 | — | — | 1 |
Coronary disease | D003327 | — | — | — | — | 1 | — | — | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 1 | — | — | 1 |
Body weight changes | D001836 | — | — | — | — | 1 | — | — | 1 |
Asthma | D001249 | EFO_0000270 | J45 | — | — | 1 | — | — | 1 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glucose intolerance | D018149 | HP_0000833 | R73.03 | — | 1 | — | — | 1 | 2 |
Therapeutics | D013812 | — | — | — | 1 | — | — | — | 1 |
Oxidative stress | D018384 | EFO_1001905 | — | — | 1 | — | — | — | 1 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
Lymphoma | D008223 | — | C85.9 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Heart disease risk factors | D000082742 | — | — | — | — | — | — | 1 | 1 |
Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
Hemostasis | D006487 | — | — | — | — | — | — | 1 | 1 |
Fetal macrosomia | D005320 | — | — | — | — | — | — | 1 | 1 |
Kidney transplantation | D016030 | — | — | — | — | — | — | 1 | 1 |
Pregnancy complications | D011248 | — | — | — | — | — | — | 1 | 1 |
Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 1 | 1 |
Drug common name | — |
INN | — |
Description | — |
Classification | — |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | — |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |